Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Recent advances in pharmacology, molecular biology, and genetics on the serotonin system hold out the promise of the development of improved pharmacological treatment for some aspects of neurological diseases. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 102 pages - $1,495
Sep 2011 - 97 pages - $3,500
Apr 2010 - 20 pages - $125
Nov 2010 - 40 pages - $500
Mar 2011 - 27 pages - $125
May 2011 - 34 pages - $500
Jun 2011 - 34 pages - $125
Jun 2006 - 1068 pages - $2,495
Jan 2011 - 78 pages - $1,000
Jul 2011 - 39 pages - $5,700
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us